Repopulation of decellularised articular cartilage by laser-based matrix engraving

Current treatments for cartilage defects often fail to maintain long-term effectiveness due to declining clinical outcomes. Scaffold materials used in clinical settings have limitations in mimicking the natural biomechanical properties and cellular environment of native cartilage. While cell and scaffold-based strategies have advanced, they still fall short in providing durable and functional repair. Prior research has shown that scaffolds must support both mechanical integrity and cell viability to promote regeneration. However, no prior work had resolved how to achieve a scaffold that mimics native cartilage structure and function. The gap motivated the development of new biomaterials that better support chondrogenesis. This paper's contribution lies in proposing a decellularised cartilage scaffold with laser-engraved features. The study addresses the need for a scaffold that guides cell distribution and matrix deposition in a way that mirrors natural cartilage organization.

The aim of this study was to develop and evaluate a novel scaffold material for cartilage regeneration. The specific problem addressed is the lack of scaffolds that provide both suitable biomechanical properties and a supportive environment for regenerative cells. The motivation stems from the clinical need for long-term solutions to cartilage defects. The scaffold was designed to overcome limitations of current materials by using decellularised human articular cartilage. The study aimed to assess the scaffold's mechanical properties, cell adhesion, and chondrogenic potential. The researchers also sought to compare the new scaffold with a commercial collagen-based scaffold. A key objective was to determine whether laser-engraved features could guide cell distribution and matrix deposition. The ultimate goal was to improve clinical outcomes by enhancing tissue integration and biomechanical function.

The scaffold was created from decellularised human articular cartilage using a CO₂ laser to engrave the matrix. The process included glycosaminoglycan removal and DNA quantification to ensure decellularisation. Mechanical testing was performed to assess the scaffold's biomechanical properties. In vitro experiments involved culturing adipose-derived stromal cells (ASC) on the scaffold to evaluate cell vitality, adhesion, and chondrogenic differentiation. An ectopic mouse model was used to study in vivo performance, combining the scaffold with ASC, human chondrocytes, and bovine chondrocytes. The scaffold was compared to a commercial collagen type I/III scaffold. Crossed line engravings were used to create a uniform cell distribution pattern. Chemical and enzymatic treatments were applied to enhance cell adhesion and scaffold integration.

The novel scaffold, termed CartiScaff, demonstrated superior biomechanical properties compared to commercial collagen scaffolds. In vitro tests showed that ASC adhered well to the scaffold and exhibited chondrogenic differentiation. The laser incisions guided new collagen fibres towards vertical alignment, a feature of native cartilage. In the ectopic mouse model, chondrocytes and mesenchymal stromal cells differentiated within the scaffold incisions without growth factors or load. Neo-tissue integrated well into the scaffold matrix. Bone marrow-derived cells repopulated empty chondrocyte lacunae within the scaffold. The scaffold's chondrogenic microenvironment was evident despite the lack of external stimuli. These findings suggest that CartiScaff supports both cell function and matrix deposition in a way that mimics natural cartilage.

The study's findings suggest that CartiScaff offers a promising solution for cartilage defect treatment. The scaffold's superior biomechanical properties and chondrogenic microenvironment support tissue regeneration. Laser incisions guided matrix deposition and cell alignment, resembling native cartilage structure. The scaffold's ability to repopulate empty lacunae with bone marrow-derived cells was notable. The results indicate that CartiScaff may improve long-term clinical outcomes by accelerating rehabilitation. The scaffold's performance in an unloaded in vivo model supports its potential for clinical use. The authors propose that CartiScaff's design enhances tissue integration and biomechanical function. These findings align with the study's aim to develop a scaffold that overcomes current limitations in cartilage repair.